Filter
630
Filtered Results: 630
Text search:
pharmacy
quality
assurance
Featured
Recommendations
57
New Publications
242
Language
Document type
No document type
390
Guidelines
93
Studies & Reports
73
Manuals
32
Strategic & Response Plan
19
Training Material
10
Situation Updates
7
Fact sheets
6
Countries / Regions
Kenya
49
Ethiopia
31
India
30
Uganda
25
Sierra Leone
24
Nigeria
23
South Africa
21
Rwanda
20
Malawi
20
Nepal
19
Namibia
19
Ghana
18
Tanzania
18
Liberia
17
Zambia
13
Botswana
12
Bangladesh
11
Zimbabwe
10
Congo, Democratic Republic of
9
Lesotho
8
Myanmar / Burma
7
Senegal
6
Philippines
6
Global
6
Western and Central Europe
6
Benin
4
Cameroon
4
Burkina Faso
4
Cambodia
4
Latin America and the Carribbean
4
Pakistan
4
Africa
3
Haiti
3
Jordan
3
Indonesia
3
Eswatini/ Swaziland
3
Ukraine
2
Afghanistan
2
Mozambique
2
Asia
2
South–East Asia Region
2
Eastern Europe
2
Bhutan
2
Tajikistan
1
Timor Leste/ East Timor
1
Thailand
1
Australia
1
Syria
1
Albania
1
Laos
1
Niger
1
Germany
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Maldives
1
Mauritius
1
United Kingdom
1
East and Southern Africa
1
Lebanon
1
Sri Lanka
1
Russia
1
Sudan
1
Yemen
1
Georgia
1
Central African Republic
1
Mali
1
Chad
1
South Sudan
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
404
Clinical Guidelines
28
Key Resources
21
Public Health
18
Women & Child Health
16
Pharmacy & Technologies
14
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
Pharmacy
70
AMR
59
TB
34
HIV
25
Caregiver
15
COVID-19
12
Mental Health
9
NTDs
5
NCDs
5
Conflict
5
Rapid Response
4
Ebola & Marburg
4
Global Health Education
4
Refugee
3
Disability
3
Zika
2
Polio
2
Cholera
1
Planetary Health
1
Health Financing Toolbox
1
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
Sixth edition
2007
This survey is part of a series of eight country surveys conducted in the context of the People that Deliver Initiative (peoplethatdeliver.org). This global initiative, which brings together the world’s largest organizations, aims to improve health services performance through the professionalizat...
Curricular Modules for Lecturers and Teachers.
The 2nd edition of the Global Public Health Curriculum has been published in the South Eastern European Journal of Public Health, end of 2016 as a special volume . The curriculum targets the postgraduate education and training of public health professi...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio...
Guidance on Implending Publi-Private Mix Approaches
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
